Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.

Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.
复制标题

DOI:
10.1016/j.neuron.2009.07.019
复制
发表时间:
2009-08-13
期刊:
影响因子:
16.2
通讯作者:
Pennuto, Maria
Pennuto, Maria
中科院分区:
医学1区
文献类型:
--
作者:
Palazzolo, Isabella;Stack, Conor;Kong, Lingling;Musaro, Antonio;Adachi, Hiroaki;Katsuno, Masahisa;Sobue, Gen;Taylor, J. Paul;Sumner, Charlotte J.;Fischbeck, Kenneth H.;Pennuto, Maria

文献摘要

参考文献

被引文献

相似文献

雄激素受体(AR)中多聚谷氨酰胺束的扩张导致脊髓和延髓肌萎缩(SBMA)。我们以前已经表明,Akt介导的AR磷酸化减少配体结合,减弱突变体AR的毒性。在这里,我们表明,在培养的细胞中,胰岛素样生长因子1(IGF-1)减少AR聚集和增加AR清除通过泛素-蛋白酶体系统通过Akt的AR磷酸化。为了评估外源性IGF-1在体内的潜在益处,我们将SBMA小鼠与在骨骼肌中选择性过表达IGF-1的肌肉特异性亚型的小鼠杂交。在由此产生的后代中,我们发现Akt活化和AR磷酸化增加以及AR聚集减少的证据。IGF-1/Akt信号的增强挽救了SBMA小鼠的行为和组织病理学异常,延长了寿命并减少了肌肉和脊髓病理学。这项研究建立了IGF-1/Akt介导的突变型AR失活作为体内对抗疾病的策略,并首次证明骨骼肌是SBMA治疗干预的可行靶组织。
Expansion of a polyglutamine tract in the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA). We have previously shown that Akt-mediated phosphorylation of AR reduces ligand binding and attenuates the toxicity of mutant AR. Here we show that in cultured cells insulin-like growth factor 1 (IGF-1) reduces AR aggregation and increases AR clearance via the ubiquitin-proteasome system through phosphorylation of AR by Akt. To evaluate the potential benefit of exogenous IGF-1 in vivo, we crossed SBMA mice with mice that overexpress a muscle-specific isoform of IGF-1 selectively in skeletal muscle. In the resulting offspring, we found evidence of increased Akt activation and AR phosphorylation and decreased AR aggregation. Augmentation of IGF-1/Akt signaling rescued behavioral and histopathological abnormalities, extended the life span and reduced both muscle and spinal cord pathology of SBMA mice. This study establishes IGF-1/Akt-mediated inactivation of mutant AR as a strategy to counteract disease in vivo and demonstrates for the first time that skeletal muscle is a viable target tissue for therapeutic intervention in SBMA.
DOI: 10.1074/jbc.270.20.12109
发表时间: 1995-05-19
影响因子: 4.8
作者:
COLEMAN, ME;DEMAYO, F;SCHWARTZ, RJ
通讯作者: SCHWARTZ, RJ
DOI: 10.1016/s0896-6273(02)00834-6
发表时间: 2002-08-29
期刊: NEURON
影响因子: 16.2
作者:
Katsuno, M;Adachi, H;Sobue, G
通讯作者: Sobue, G
DOI: 10.1126/science.1086137
发表时间: 2003-08-08
期刊: SCIENCE
影响因子: 56.9
作者:
Kaspar, BK;Lladó, J;Gage, FH
通讯作者: Gage, FH
DOI: 10.1212/wnl.51.2.583
发表时间: 1998-08-01
期刊: NEUROLOGY
影响因子: 9.9
作者:
Borasio, GD;Robberecht, W;Dobbins, T
通讯作者: Dobbins, T
DOI: 10.1093/emboj/cdf406
发表时间: 2002-08-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Lin, HK;Wang, L;Chang, CS
通讯作者: Chang, CS